Soleus Capital Management’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

Soleus Capital Management’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-318,269	Closed	-$10.6M	–	111
2024 Q3	$10.6M	Buy	+318,269	New	+$11M	0.82%	39

Soleus Capital Management's LBPH Position: Q4 2024 in Review

Soleus Capital Management sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 318,269 shares — an estimated $10.6M sold.

Soleus Capital Management first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $10.6M in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

Soleus Capital Management reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Soleus Capital Management sold 318,269 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $10.6M.
Soleus Capital Management first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
Soleus Capital Management's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $10.6M in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on Soleus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.